Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from Healius Limited ( (AU:HLS) ) is now available.
Healius Limited has released its 2025 Corporate Governance Statement, highlighting its commitment to high standards of corporate governance in alignment with ASX Recommendations. The statement outlines the company’s governance framework, emphasizing ethical conduct and social responsibility, with the Board and its committees overseeing various aspects such as risk management and remuneration.
The most recent analyst rating on (AU:HLS) stock is a Hold with a A$0.87 price target. To see the full list of analyst forecasts on Healius Limited stock, see the AU:HLS Stock Forecast page.
More about Healius Limited
Healius Limited operates in the healthcare industry, focusing on diagnostics and medical services. The company is committed to maintaining a strong corporate governance framework to ensure long-term success.
Average Trading Volume: 4,967,969
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$548.2M
See more insights into HLS stock on TipRanks’ Stock Analysis page.